Financials
- Market Capitalization 722.08 M
- Employee 152
- Founded 2017
- CEO N/A
- Website www.allogene.com
- Headquarter California, United States
- FIGI BBG00KHRRDX3
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.57
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2683 | BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 9.18 USD | -0.86% | -0.11% | +6.25% | -4.87% | 736.00 M USD | ||
| 2691 | PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 8.94 USD | +1.94% | +3.59% | -25.00% | -28.25% | 723.25 M USD | ||
| 2699 | TECX Tectonic Therapeutic, Inc. - Common Stock | 36.70 USD | +2.03% | +0.77% | +23.03% | +113.99% | 717.46 M USD | ||
| 2707 | ASMB Assembly Biosciences, Inc. - Common Stock | 34.80 USD | -1.75% | +2.78% | +35.15% | +18.27% | 708.55 M USD |